DE HB54 | 2023-2024 | 152nd General Assembly
Status
Completed Legislative Action
Spectrum: Partisan Bill (Democrat 21-1)
Status: Passed on May 25 2023 - 100% progression
Action: 2023-05-25 - Signed by Governor
Text: Latest bill text (Draft #1) [HTML]
Spectrum: Partisan Bill (Democrat 21-1)
Status: Passed on May 25 2023 - 100% progression
Action: 2023-05-25 - Signed by Governor
Text: Latest bill text (Draft #1) [HTML]
Summary
Currently, all health insurance plans subject to requirements under Delaware law must include at least 1 formulation of epinephrine autoinjectors on the lowest tier of the carrier's drug formulary for individuals who are 18 years of age or younger. This Act expands this requirement to all covered individuals, regardless of age, by January 1, 2024.
Title
An Act To Amend Title 18, Title 29, And Title 31 Of The Delaware Code Relating To Insurance Coverage Of Epinephrine Autoinjectors.
Sponsors
Roll Calls
2023-05-09 - Senate - Senate Third Reading (Y: 20 N: 1 NV: 0 Abs: 0) [PASS]
2023-03-14 - House - House Third Reading (Y: 39 N: 0 NV: 0 Abs: 2) [PASS]
2023-03-14 - House - House Third Reading (Y: 39 N: 0 NV: 0 Abs: 2) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2023-05-25 | Signed by Governor | |
| 2023-05-09 | Passed By Senate. Votes: 20 YES 1 NO | |
| 2023-04-05 | Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 3 Favorable, 3 On Its Merits | |
| 2023-03-14 | Assigned to Banking, Business, Insurance & Technology Committee in Senate | |
| 2023-03-14 | Passed By House. Votes: 39 YES 2 ABSENT | |
| 2023-03-07 | Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 7 Favorable, 5 On Its Merits | |
| 2023-01-19 | Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House |
